8-K: QT Imaging Secures $18.18M Private Placement for Growth

QT Imaging Holdings, Inc. announced an $18.18 million private placement to fund growth initiatives and repay debt, with plans to relist on NASDAQ.

Summary

• QT Imaging Holdings, Inc. entered into a Securities Purchase Agreement for a private placement, raising approximately $18,180,654.59 in gross proceeds.
• The private placement involved the issuance of 6,696,715 shares of common stock at $1.50 per share, up to 5,424,083 prefunded warrants at $1.4999 per warrant (exercisable at $0.0001), and Subscription Warrants for up to 12,120,798 additional common shares (exercisable at $1.50, 6 months after issuance, for 5 years).
• The company intends to use the net proceeds for working capital, including repaying $5 million of its senior secured term loan with Lynrock Lake Master Fund LP.
• Funds will also support expanding U.S.A. and global go-to-market activities and deploying the QTI Cloud Platform.
• The closing of the financing is expected to occur on October 3, 2025.
• Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent, receiving a 6.0% cash fee on gross proceeds (with exceptions) and up to $100,000 in expense reimbursement.
• The company agreed to file a registration statement for the resale of the securities within 30 calendar days and seek effectiveness within 90-120 days.
• QT Imaging plans to apply for a Nasdaq listing for its Common Stock, including all newly issued shares and warrant shares, within 30 days of the closing.
• A reverse stock split of the Common Stock is planned within 15 days of closing to facilitate the Nasdaq listing.

Sentiment

Score: 8

Explanation: The successful private placement provides substantial capital for QT Imaging's strategic initiatives, including debt reduction and market expansion. The planned NASDAQ relisting is a strong positive signal for future growth and investor visibility. While dilution is a factor, the overall impact of securing this funding and strategic direction is highly favorable.

Positives

• Secured approximately $18.18 million in gross proceeds from accredited and institutional investors, including Sio Capital Management.
• Financing strengthens the balance sheet and provides capital for strategic growth initiatives.
• Proceeds will be used to repay $5 million of outstanding senior secured debt, reducing financial leverage.
• Funds are allocated to expand U.S.A. and global go-to-market activities and deploy the QTI Cloud Platform, indicating a clear growth strategy.
• The company is initiating the process to relist on NASDAQ, which could enhance liquidity and investor visibility.
• The participation of healthcare specialist investors like Sio Capital Management signals confidence in the company's vision.

Negatives

• The private placement involves significant dilution through the issuance of new common stock and warrants, potentially increasing the total outstanding shares by a substantial amount upon full exercise.
• Placement agent fees of 6.0% of gross proceeds and up to $100,000 in expenses will reduce the net proceeds available to the company.
• The company is obligated to implement a reverse stock split within 15 days of closing for Nasdaq listing purposes, which can sometimes be perceived negatively by the market.
• The company is subject to liquidated damages (1% of subscription amount per month) if it fails to timely file or achieve effectiveness for the resale registration statement.

Risks

• Ability to sell and deploy the QT Imaging Breast Acoustic CT Scanner.
• Ability to extend product offerings into new areas or products.
• Ability to commercialize technology.
• Unexpected occurrences that deter the full documentation and bring-to-market plan for products.
• Trends and fluctuations in the industry.
• Changes in demand and purchasing volume of customers.
• Unpredictability of suppliers.
• Ability to attract and retain qualified personnel.
• Ability to move product sales to production levels.
• Changes in domestic and foreign business, market, financial, political, and legal conditions.
• Uncertainty of projected financial information.
• Delays caused by factors outside of control.
• Changes in ability to successfully receive purchase orders and generate revenue under existing contracts.
• Ability to realize the benefits of strategic partnerships.
• Identified material weakness in internal controls over financial reporting (including the timeline to remediate).
• Rollout of the business and the timing of expected business milestones.
• Effects of competition on future business.
• Ability to obtain and access financing in the future.
• Ability to pay debt obligations as they come due.

Future Outlook

The company expects to use the net proceeds to enhance its balance sheet, repay $5 million of debt, and significantly expand its U.S.A. and global go-to-market activities. It also plans to deploy its QTI Cloud Platform and is making final preparations to relist on NASDAQ, which is viewed as an important inflection point for the business and global growth strategy.

Management Comments

• "We appreciate the support of this high-conviction group of healthcare specialist investors that shares the vision of transforming QTI into a precision imaging AI company."
• "Today marks an important inflection point for our business."
• "With this investment, together with our existing cash, we are very well-positioned to continue executing our global growth strategy."
• "This also comes at an especially opportune time as we make final preparations to relist on the NASDAQ."

Industry Context

The financing positions QT Imaging to advance its medical device and imaging systems, particularly the Breast Acoustic CT Scanner and QTI Cloud Platform. This aligns with broader industry trends towards precision imaging, AI integration in healthcare, and expanding global market reach for innovative medical technologies. The move to relist on NASDAQ suggests an aim for increased visibility and access to a larger investor base, common for growth-oriented medical technology companies.

Corporate Governance

Related Party Transactions

• Repayment of $5 million of outstanding principal in accordance with the terms of the First Amendment to the Credit Agreement with Lynrock Lake Master Fund LP, as disclosed in a Current Report on Form 8-K on August 28, 2025.

Stakeholder Impact

• Shareholders: Potential for significant dilution from the issuance of new shares and warrants. However, the capital raise strengthens the company's financial position and supports growth initiatives, which could lead to long-term value creation. The planned NASDAQ relisting could improve liquidity and investor access.
• Creditors: The repayment of $5 million of the senior secured term loan with Lynrock Lake Master Fund LP reduces the company's debt obligations, improving its credit profile.
• Employees: Enhanced financial stability and growth initiatives could lead to job security and potential expansion opportunities.
• Customers: Investment in go-to-market activities and the QTI Cloud Platform could lead to improved product availability, support, and new offerings.

Next Steps

• Closing of the Private Placement expected on or before October 3, 2025.
• Company to apply to list Common Stock on Nasdaq Capital Market, Nasdaq Global Market, or Nasdaq Global Select Market within 30 days of closing.
• Company to implement a reverse stock split of the Common Stock within 15 days of closing for Nasdaq Listing purposes.
• Company to file a registration statement covering the resale of all Registrable Securities within 30 calendar days of September 30, 2025.
• Company to cause the registration statement to be declared effective by the SEC within 90 calendar days (or 120 days if full SEC review).
• Subscription Warrants will become exercisable 6 months after issuance.

Key Dates

Recommendation

The successful private placement of over $18 million, anchored by a reputable healthcare specialist investor, significantly bolsters QT Imaging's financial position. The strategic allocation of funds towards debt reduction and aggressive go-to-market expansion, coupled with the clear intent to relist on NASDAQ, signals a strong commitment to growth and enhanced shareholder value. While dilution is a factor, the capital infusion and strategic direction outweigh this, positioning the company for improved operational capabilities and market visibility. The planned reverse stock split is a necessary step for the NASDAQ relisting, which is a net positive for long-term liquidity and institutional interest.

Keywords

QT Imaging Holdings, QTIH, Private Placement, PIPE financing, Equity Financing, Warrants, Common Stock, Sio Capital Management, Ladenburg Thalmann, NASDAQ relisting, Medical Device, Breast Acoustic CT Scanner, QTI Cloud Platform, Working Capital, Debt Repayment, Healthcare Investors, SEC Filing, Form 8-K